Fund Holdings — Rosalind Advisors, Inc.

Total Portfolio Value:
$274.46M
Total Bought:
$43.91M
Total Sold:
$73.02M
Net Transaction:
-$29.11M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Delcath Systems, Inc.(DCTH)3,300,3893,300,3890$33.00M$33.00M12.02%$0
Savara Inc.(SVRA)4,000,0003,403,721-596,279$14.28M$20.52M7.48%+$6.24M
Fennec Pharmaceuticals Inc.(FENC)2,076,8402,613,508+536,668$19.44M$20.12M7.33%+$684.8K
Xeris Biopharma Holdgs Inc1,795,7662,111,700+315,934$14.62M$16.58M6.04%+$1.96M
Viridian Therapeutics, Inc.(VRDN)600,000450,000-150,000$12.95M$14.00M5.10%+$1.06M
MediWound Ltd.SHS NEW(MDWD)749,054749,0540$13.50M$13.83M5.04%+$329.6K
Verastem, Inc.(VSTM)1,929,5631,788,475-141,088$17.04M$13.81M5.03%-$3.23M
Replimune Group, Inc.(REPL)01,410,497+1,410,497$0$13.71M5.00%+$13.71M
Astria Therapeutics Inc1,039,0801,039,0800$7.56M$13.60M4.96%+$6.04M
Cybin D/B/A Helus Pharma(HELP)1,500,0001,657,540+157,540$8.84M$13.56M4.94%+$4.72M
EyePoint, Inc.(EYPT)650,000690,000+40,000$9.26M$12.61M4.59%+$3.35M
CG Oncology, Inc.(CGON)300,000300,0000$12.08M$12.46M4.54%+$372.0K
Cytokinetics, Incorporated(CYTK)400,000195,045-204,955$21.98M$12.39M4.52%-$9.59M
X4 Pharmaceuticals, Inc.(XFOR)1,544,6072,605,920+1,061,313$5.28M$10.42M3.80%+$5.14M
Mind Medicine Mindmed Inc750,000750,0000$8.84M$10.04M3.66%+$1.20M
Profound Medical Corp.(PROF)692,1851,068,955+376,770$3.38M$8.41M3.07%+$5.03M
InspireMD, Inc.(NSPR)3,905,7433,905,7430$9.41M$6.95M2.53%-$2.46M
Ocular Therapeutix, Inc.(OCUL)400,000400,0000$4.68M$4.86M1.77%+$180.0K
ArriVent BioPharma, Inc.(AVBP)0215,871+215,871$0$4.34M1.58%+$4.34M
Talphera, Inc.(TLPH)4,385,7573,579,273-806,484$3.92M$4.08M1.49%+$163.0K
Myomo, Inc.(MYO)3,790,7883,839,772+48,984$3.38M$3.49M1.27%+$112.8K
PolyPid Ltd.(PYPD)918,668696,556-222,112$3.06M$3.02M1.10%-$40.7K
OnKure Therapeutics, Inc.CL A(OKUR)0730,488+730,488$0$2.12M0.77%+$2.12M
Regentis Biomaterials Ltd.(RGNT)0251,510+251,510$0$1.70M0.62%+$1.70M
Trevi Therapeutics, Inc.(TRVI)100,000100,0000$915.0K$1.25M0.46%+$337.0K
NeurAxis, Inc.(NRXS)0286,138+286,138$0$1.04M0.38%+$1.04M
Kura Oncology, Inc.(KURA)100,000100,0000$885.0K$1.04M0.38%+$154.0K
Fractyl Health, Inc.(GUTS)5,000,000385,731-4,614,269$7.95M$848.6K0.31%-$7.10M
Biofrontera Inc.(BFRI)1,140,7641,140,7640$1.12M$650.2K0.24%-$473.4K
Astria Therapeutics Inc1,542,5200-1,542,520$1.11M$0—-$1.11M
IDEAYA Biosciences, Inc.(IDYA)350,0000-350,000$9.52M$0—-$9.52M
Rezolute, Inc.(RZLT)1,807,2020-1,807,202$16.99M$0—-$16.99M
uniQure N.V.SHS(QURE)125,0000-125,000$7.30M$0—-$7.30M
Verona Pharma PlcADS100,0000-100,000$10.67M$0—-$10.67M
Page 1 of 1
Rosalind Advisors, Inc. — 13F Holdings — Q4 2025 | TickerTrail